Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Understanding the power of the MMP and where we can find revenues is a PRIORITY,

"The T3 case will finally tell us whether we have a patent on water or just BS."

Again, I agree with what you write with a caveat.

Only TPL knows how close they are to MMP license deals and how they project future revenue flow. Maybe the PTSC board knows something too - but only what they are told by TPL. So TPL or 'people in the know' (aka Insiders?) are in the wonderful positions of (a) knowing better than any what the future holds and (b) controlling the income flow to PTSC.

Share
New Message
Please login to post a reply